Resumen
The synthesis of a third generation triazine dendrimer, 1, containing multiple, iron-sequestering desferrioxamine B (DFO) groups is described. Benzoylation of the hydroxamic acid groups of DFO and formation of a reactive dichlorotriazine provide the intermediate for reaction with the second generation dendrimer displaying twelve amines. This strategy further generalizes the 'functional monomer' approach to generate biologically active triazine dendrimers. Dendrimer 1 is prepared in seven steps in 35% overall yield and displays 12 DFO groups making it 56% drug by weight. Spectrophotometric titrations (UV-vis) show that 1 sequesters iron(III) atoms with neither cooperativity nor significant interference from the dendrimer backbone. Evidence from NMR spectroscopy and mass spectrometry reveals a limitation to this functional monomer approach: trace amounts of O-to-N acyl migration from the protected hydroxamic acids to the amine-terminated dendrimer occurs during the coupling step leading to N-benzoylated dendrimers displaying fewer than 12 DFO groups.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 5749-5753 |
| Número de páginas | 5 |
| Publicación | Bioorganic and Medicinal Chemistry |
| Volumen | 18 |
| N.º | 15 |
| DOI | |
| Estado | Published - ago 1 2010 |
Nota bibliográfica
Funding Information:The authors acknowledge support of the NIH ( R01 NIGMS 65640 ) and the Robert A. Welch Foundation ( A 1439 ).
Financiación
The authors acknowledge support of the NIH ( R01 NIGMS 65640 ) and the Robert A. Welch Foundation ( A 1439 ).
| Financiadores | Número del financiador |
|---|---|
| Robert A. Welch Foundation | A 1439 |
| National Institutes of Health (NIH) | R01 NIGMS 65640 |
| National Institute of General Medical Sciences | R01GM064560 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry